A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040

NCT00562848 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroparesis

Interventions

DRUG: GSK962040
DRUG: Placebo

Sponsor

GlaxoSmithKline